Clinical Trials Logo

Spinal Metastases clinical trials

View clinical trials related to Spinal Metastases.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06173401 Recruiting - Spinal Metastases Clinical Trials

Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases

Start date: December 18, 2023
Phase: Phase 3
Study type: Interventional

The goal of this study is to determine whether fractionated Stereotactic radiosurgery (SRS) for spine metastases is associated with improved local tumor control compared to single-fraction SRS. Patients will be randomized to treatment with spine SRS using either 22 Gy in 1 fraction or 28 Gy in 2 fractions.

NCT ID: NCT06120426 Recruiting - Surgery Clinical Trials

En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor.

Start date: July 1, 2023
Phase:
Study type: Observational [Patient Registry]

The purpose of this clinical trial is to explore the impact of En bloc surgery and separation surgery combined with radiation therapy on the prognosis and survival of patients with spinal oligometastatic cancer, describe the clinical results, and optimize future treatment goals

NCT ID: NCT05589701 Recruiting - Spinal Metastases Clinical Trials

Comparing SBRT to CRT in Patients With Spinal Metastases

COMBAT
Start date: December 12, 2022
Phase:
Study type: Observational [Patient Registry]

This is a single institutional registry-based, prospective, observational study to describe radiation oncologists' decision making during evaluation of patients and to compare real-world outcomes of SBRT vs CRT. A registry-based trial involves observing the effect of something without manipulating it.

NCT ID: NCT05575323 Recruiting - Spinal Metastases Clinical Trials

Randomized Trial on Same-day SBRT and Surgical Stabilization for Symptomatic Spinal Metastases

BLEND
Start date: October 15, 2022
Phase: N/A
Study type: Interventional

The BLEND RCT aims to evaluate the (cost-)effectiveness of same-day SBRT and surgical stabilization with or without decompression for the treatment of symptomatic, unstable spinal metastases on physical functioning four weeks after the start of treatment, compared with the standard of care (surgery followed by radiotherapy as soon as the wound healed sufficiently).

NCT ID: NCT04863612 Recruiting - Spinal Metastases Clinical Trials

SBRT in the Management of Solid Spinal Metastases

Start date: May 18, 2021
Phase:
Study type: Observational [Patient Registry]

Documenting efficiency of SBRT in the management of epidural spinal metastases from solid tumors

NCT ID: NCT04497051 Recruiting - Surgery Clinical Trials

CT-DSA Evaluation of Embolization in Debulking Spinal Surgery

Start date: August 1, 2020
Phase:
Study type: Observational

Vertebra is one of the most common site of metastatic disease, which may cause severe pain or neurological deficit. Decompressive surgery or radiation therapy are of limited efficacy and recurrence is very likely. Debulking surgery usually has better local control and survival benefit. However, debulking surgery often accompany with massive blood loss, which may cause hemorrhagic shock or death. It is known that intraoperative blood loss is associated with tumoral vascularity. However, there is current no objective method to evaluate vascularity status. On the other hand, preoperative embolization is considered as major method to decrease blood loss. There is also objective method to evaluate the embolization effect. By our innovative dual energy computed tomography angiography - digital subtraction angiography (CT-DSA), the tumoral vascularity status and embolization effect of spinal tumor can be objectively assessed. We aim to utilize CT-DSA to investigate spinal tumor, in a hope to find out correlation of vascularity status, embolization method, and surgical outcome, which can help individual disease status and tailored treatment decision. Key word: spine/embolization/computed tomography

NCT ID: NCT04248543 Recruiting - Spinal Metastases Clinical Trials

Quantitative MRI for Functional Assessment Following SBRT for Spinal Metastases

Start date: December 22, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if quantitative magnetic resonance imaging (qMRI) can objectively measure changes in the tumor/vertebral body and adjacent spinal cord following stereotactic body radiation therapy (SBRT) for painful metastatic spine disease.

NCT ID: NCT03398915 Recruiting - Clinical trials for Degenerative Disc Disease

The European Robotic Spinal Instrumentation (EUROSPIN) Study

EUROSPIN
Start date: February 20, 2018
Phase:
Study type: Observational [Patient Registry]

In a multinational prospective study, preoperative, intraoperative, perioperative and follow-up data on patients receiving thoracolumbar pedicle screw placement for degenerative disease or infections or tumors will be collected. The three arms consist of robot-guided (RG), navigated (NV), or freehand (FH) screw insertion.

NCT ID: NCT03365973 Recruiting - Breast Cancer Clinical Trials

Pathological Fracture in Potentially Unstable Spinal Metastases of Breast Cancer

Start date: December 15, 2017
Phase:
Study type: Observational

The purpose of this study is to identify potential risk factors for and determine the rate of pathological fracture for patients which having spine metastases from breast cancer and be defined as potentially unstable (SINS 7-12) according to the Spinal Instability Neoplastic Score (SINS). The investigators' analysis will provide robust data about the development of spinal instability and help identify the optimal timing of local surgery treatment.

NCT ID: NCT03363685 Recruiting - Spinal Metastases Clinical Trials

Verification of Novel Survival Prediction Algorithm for Patients With NSCLC Spinal Metastasis

Start date: November 1, 2017
Phase:
Study type: Observational

The purpose of this study is to learn whether our own made predictive algorithm can be used as a clinical practical decision support for patients with NSCLC spinal metastasis. The scoring system consists of the use of EGFR-TKI, KPS, Age, SCC, CA125 and smoking history. By predicting survival doctors could determine which patients are suitable for palliative therapy.